Related Experiment Video
Updated: Jun 3, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
Evaluating the Relationship between Cathepsins and Papillary Thyroid Carcinoma: A Mendelian Randomization Study
Liu Muge1, Xiao Xiongsheng1, Jin Ling2
1Department of Vascular and Thyroid Surgery, Affiliated Hospital of Guangdong Medical University, Guangdong, China.
Endocrine, Metabolic & Immune Disorders Drug Targets
|January 10, 2025
Summary
This study reveals a causal link between elevated cathepsin levels and increased risk of papillary thyroid carcinoma (PTC). Cathepsin Z, in particular, plays a significant role in PTC development, suggesting potential new therapeutic targets.
Area of Science:
- Genetics
- Oncology
- Biochemistry
Background:
- Papillary Thyroid Carcinoma (PTC) is the most prevalent thyroid malignancy.
- The precise etiology and progression of PTC remain incompletely understood.
- A potential link between cathepsins and PTC exists, but its causal nature requires investigation.
Purpose of the Study:
- To investigate the potential causal influence of cathepsins on the risk of developing papillary thyroid carcinoma.
- To utilize Mendelian Randomization (MR) to explore this genetic association.
Main Methods:
- Employed univariable and multivariable Mendelian Randomization (MR) analyses.
- Utilized genetic variants as instrumental variables for cathepsin levels.
- Sourced cathepsin genetic data from the INTERVAL study and PTC data from the Finnish Genome-Wide Association Study.
Main Results:
- MR analyses indicated a significant causal association between higher cathepsin levels and increased PTC risk.
- Genetic variants associated with higher cathepsin Z expression showed a positive causal link with PTC risk (OR: 1.1190).
- Multivariable analysis confirmed cathepsin Z's significant role in PTC carcinogenesis (OR: 1.1593).
Conclusions:
- Established a causal relationship between cathepsin levels and PTC risk.
- Highlighted the specific role of cathepsin Z in PTC progression.
- Suggests potential for novel therapeutic strategies targeting cathepsin enzymes in PTC treatment.

